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Background: Low or high prepregnancy body mass index (BMI) and inadequate or excess gestational weight gain
(GWG) are associated with adverse neonatal outcomes. This study estimates the contribution of these risk factors to
preterm births (PTBs), small-for-gestational age (SGA) and large-for-gestational age (LGA) births in Canada compared
to the contribution of prenatal smoking, a recognized perinatal risk factor.
Methods: We analyzed data from the Canadian Maternity Experiences Survey. A sample of 5,930 women who had
a singleton live birth in 2005-2006 was weighted to a nationally representative population of 71,200 women. From
adjusted odds ratios, we calculated population attributable fractions to estimate the contribution of BMI, GWG and
prenatal smoking to PTB, SGA and LGA infants overall and across four obstetric groups.
Results: Overall, 6% of women were underweight (<18.5 kg/m2) and 34.4% were overweight or obese (≥25.0 kg/m2).
More than half (59.4%) gained above the recommended weight for their BMI, 18.6% gained less than the
recommended weight and 10.4% smoked prenatally. Excess GWG contributed more to adverse outcomes than BMI,
contributing to 18.2% of PTB and 15.9% of LGA. Although the distribution of BMI and GWG was similar across obstetric
groups, their impact was greater among primigravid women and multigravid women without a previous PTB or
pregnancy loss. The contributions of BMI and GWG to PTB and SGA exceeded that of prenatal smoking.
Conclusions: Maternal weight, and GWG in particular, contributes significantly to the occurrence of adverse neonatal
outcomes in Canada. Indeed, this contribution exceeds that of prenatal smoking for PTB and SGA, highlighting its
public health importance.
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Large-for-gestational ageBackground
Low or high prepregnancy body mass index (BMI) and in-
adequate or excess gestational weight gain (GWG) are
linked to an increased risk of adverse neonatal outcomes.
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and low GWG have been associated with small-for-
gestational age (SGA) infants and PTB [1-6]. Although
elevated individual-level risks have been documented in
numerous studies, less is known about population-level ef-
fects of both BMI and GWG on neonatal outcomes.
Population-level effects can be measured using popula-
tion attributable fractions (PAFs), which reflect the in-
creased risk conferred by a particular determinant and its
prevalence in the population. The PAF provides a hypo-
thetical assessment of the proportion of the outcome thatral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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making it an important outcome measure from a public
health perspective. A 2011 systematic review and meta-
analysis of risk factors for stillbirth in high-income coun-
tries concluded that 8-18% of stillbirths were attributable
to maternal overweight and obesity (BMI ≥ 25 kg/m2) [1].
In Canada, based on measured height and weight, the
prevalence of obesity among adult women rose from 16%
in 1978 to 23% in 2004 [7], reflecting a global trend in in-
creasing overweight and obesity [8]. If this trend continues,
as hypothesized by Cnattinguis et al. [9], the public health
importance of maternal overweight and obesity may rival
prenatal smoking as a modifiable risk factor for adverse
pregnancy outcomes. The objective of this study is to
examine this hypothesis for Canada, by estimating the con-
tribution of BMI and GWG, as measured by PAFs, to PTB,
SGA and LGA and to compare this to the contribution of
prenatal smoking, a recognized perinatal risk factor.
Methods
Study population
We used data from the Public Health Agency of Canada’s
Canadian Maternity Experiences Survey (MES). The MES
was a cross-sectional survey of a stratified random sample
of women drawn from the 2006 Canadian Census.
Women who had a singleton live birth in Canada between
November 2005 and May 2006, were at least 15 years of
age, living with their infant, and not living on a First
Nations reserve or in an institution were eligible to partici-
pate. Of 8,244 eligible women, 6,421 (78%) agreed to
participate. Data were collected by female interviewers be-
tween October 2006 and January 2007 using a computer-
assisted telephone interview application. Women had pre-
viously been mailed a letter which included information
on the survey and asked for their participation. Verbal
consent to participate was then obtained at the beginning
of each telephone interview. All data in this study were
based on women’s reports during survey interviews.
For this study, we excluded 491 women who were either
missing information on BMI or GWG (the principal deter-
minants of interest), missing information on gestational
age (needed for outcome variables) or were less than
18 years old because the BMI classification we used was
derived for ages 18 and older. In consideration of the sam-
ple design and non-response, each MES participant was
assigned a sampling weight. The 5,930 women in this
study were thus weighted to a nationally representative
population of 71,200 women who had a singleton live
birth in Canada between November 2005 and May 2006.
Sampling weights took into consideration the probability
of each respondent being selected from the stratified sam-
ple frame and also adjusted for non-response. Using Cen-
sus data, comparison of the respondent distribution using
the weights to the target population showed a closeapproximation on all demographic characteristics inves-
tigated (e.g., maternal age and household composition).
Detailed information on the survey’s development, includ-
ing the weighting procedure and analysis of respondent
characteristics has been reported elsewhere [10,11].
Outcomes
We studied three outcomes: PTB (<37 weeks completed
gestation), SGA (weight below the 10th percentile for
gestational age) and LGA (weight above the 90th per-
centile for gestational age). Infants were classified as
SGA or LGA using MES data on mother’s country of
birth and sex-specific growth curves developed by Ray
et al. [12]. Ray et al.’s growth curves are specific to
mother’s country of birth grouped according to seven
world regions (Canada, Europe/Western nations, Africa/
Caribbean, Middle East/North Africa, Latin America,
East Asia/South East Asia/Pacific Islands, South Asia).
Accounting for mother’s country of birth minimizes the
risk of misclassifying newborns of mothers from non-
European backgrounds as too small or too large for their
gestational age due to recognized non-pathological eth-
nic differences in birthweight [12,13]. Ray et al.’s growth
curves end at 41 weeks gestation and our sample in-
cluded 90 infants with gestational ages ranging from 42
to 45 weeks. These infants were classified using the 41-
week 10th and 90th percentile cut-offs. Fetal growth after
41 weeks gestation could have resulted in a baby being
classified in a different growth category (e.g. AGA) than
he/she would have been at 41 weeks (e.g., SGA); how-
ever any minor misclassification which may have re-
sulted from this approach was deemed preferable to
eliminating these records.
Determinants
Prepregnancy BMI and GWG measures were derived
from the following questions:
i) How tall are you without shoes on?
ii) Just before your pregnancy, how much did you weigh?
iii) How much weight did you gain during your pregnancy?
We categorized women’s prepregnancy weight accord-
ing to the World Health Organization (WHO) standard
as either being underweight (BMI < 18.5 kg/m2), normal
weight (18.5 ≤ BMI < 25), overweight (25 ≤ BMI < 30) or
obese (BMI ≥ 30).
We utilized the 2009 Institute of Medicine (IOM) guide-
lines on GWG to categorize women’s weight gain as below,
within or above recommended [14]. These guidelines have
also been adopted by Health Canada [15]. Because GWG
is associated with gestational length, we accounted for ges-
tational length in our calculations. Specifically, we assumed
a 2 kg weight gain in the first trimester (as per IOM
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ported weight gain to obtain GWG during the remainder
of the pregnancy. Next, we subtracted 13 weeks (the first
trimester) from the gestational age at birth to obtain the
number of weeks in the remainder of the pregnancy. We
then compared the GWG in the remainder of the preg-
nancy to the IOM’s recommended GWG during this
period, accounting for women’s prepregnancy BMI.
Prenatal smoking was determined from the question
“During the last 3 months of your pregnancy, did you
smoke daily, occasionally, or not at all?” Women who
responded either daily or occasionally were categorized
as smokers.
Covariates
We studied additional reproductive, health care, sociode-
mographic and psychosocial characteristics as potential
confounders of the association between BMI, GWG and
neonatal outcomes. Our selection of covariates was guided
by previous studies of risk factors for PTB, SGA and LGA
[3,4,6]. Table 1 provides definitions of the variables that
are not self-explanatory.
Statistical analysis
Percentages were used to report observed distributions
of BMI, GWG, prenatal smoking and other maternal
characteristics. Using multivariable logistic regression,
we calculated adjusted odds ratios (aORs) separately for
each outcome (PTB, SGA and LGA). For SGA analyses,
the sample was restricted to infants who were SGA and
infants who were average-for-gestational-age (AGA).
Similarly, LGA analyses were restricted to infants who
were LGA and AGA. BMI, GWG and smoking were in-
cluded in all multivariable models in order to estimate
their independent associations with each outcome.
Other covariates were selected purposely into models
using the following steps. Based on the Wald test from
univariable logistic regression models, we initially included
any variable with a p-value below 0.25 [17]. Covariates
were then removed from the model if they were statisti-
cally non-significant and not a confounder. Significance
was evaluated at the 0.05 level and confounding as aTable 1 Definition of covariate variables
Variable Definition
Low-income-cut-off (LICO) [16] A measure of the income threshold below w
average family on food, shelter and clothing
Medical condition prior to
pregnancy
Yes in response to the question “Prior to you
that required you to take medication for mor
Medical condition during
pregnancy
Yes in response to the question “During your
problems that required you to take medicatio
Depression prior to
pregnancy
Yes in response to the question “Before your
diagnosed with depression?
Short stature Height of less than 1.55 metres (5 feet 2 inchchange of 15% or greater in the effect of BMI, GWG or
smoking on the outcome being modeled. No adjustment
for multiple comparisons was used.
With the exception of maternal age, all variables were
treated as categorical in regression models. Records with
missing values for covariates other than LICO were ex-
cluded from models (<4%). Due to a large number of miss-
ing LICO values (8.0%), a missing category was included
for this variable. Calculations were carried out overall, and
for four mutually exclusive obstetric history groups: primi-
gravidas, multigravidas with a previous PTB, multigravidas
without a previous PTB but with a previous early preg-
nancy loss (miscarriage, abortion, and/or ectopic preg-
nancy) and multigravidas without a previous PTB or
previous early pregnancy loss. Analysis by these groups was
based on prior knowledge that pregnancy outcomes differ
by parity and for women with antecedent adverse outcomes
such as PTB [18,19]. Normal BMI, within recommended
GWG and non-smokers were the reference groups.
The contribution of maternal underweight, overweight
or obese BMI, less than or more than recommended
GWG, and smoking to each outcome was estimated
using PAFs. We calculated adjusted PAFs using the se-
quential and average attributable fraction method [20].
This method involves estimating a logistic regression
model with known/available confounders for each out-
come, then using this model to compute the adjusted
number of cases that would be expected if the risk factor
(e.g., excess GWG) were absent in the population. The
adjusted PAF is calculated by subtracting this number of
expected cases from the number of observed cases, then
dividing this value by the number of observed cases.
All analyses were carried out using sampling weights. Re-
sults were computed from unrounded weighted compo-
nents; however weighted sample sizes in results tables were
rounded to the nearest hundred, as unrounded estimates
overstate precision. We calculated 95% confidence intervals
for adjusted ORs and adjusted PAFs using the bootstrap
method, which accounts for the variability introduced by
the sample design and weighting adjustments [21]. Boot-
strap confidence intervals were based on 1,000 samples.
We used SAS® Enterprise Guide® software, Version 5.1 [22].hich a family will likely spend 20 percentage points more than the
r pregnancy, did you develop any medical conditions or health problems
e than 2 weeks, have special care, or extra tests during pregnancy?”
pregnancy, did you develop any new medical conditions or health
n for more than 2 weeks, have special care, or extra tests?”
pregnancy, had you ever been prescribed anti-depressants or been
es)
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Science Advisory Board, Health Canada’s Research Ethics
Board and the Federal Privacy Commissioner, and was
approved by Statistics Canada’s Policy Committee [11].
Additional ethical review was not required, as the MES
data are anonymous and this study did not generate iden-
tifying information.
Results
The distribution of BMI, GWG, smoking and covariates is
presented in Table 2. Overall, 6% of women were under-
weight and 34.4% were either overweight or obese. More
than half (59.4%) gained above the recommended weight
for their BMI; 18.6% gained less than recommended
weight; and smoking was reported by 10.4% of women.
The distribution of maternal characteristics varied across
obstetric history groups, with women with a previous PTB
reporting the highest rates of obesity (19.6%) and prenatal
smoking (17.2%) and primigravidas reporting the highest
rates of above recommended GWG (61.3%). Among
women with above recommended GWG, the average
weight gain among primigravidas was also higher (20.4 kg)
than that among multigravidas (18.9 kg). Across other
characteristics, women with a previous PTB tended to
differ from other groups of women. These differences in-
cluded lower educational achievement, having a household
income that was at or below the LICO, having medical
conditions prior to pregnancy or during pregnancy, being
diagnosed with depression prior to pregnancy and experi-
encing higher levels of stress and lower social support dur-
ing their pregnancy. Among the women who reported an
early pregnancy loss, 68.2%, 36.4% and 2.7% experienced a
miscarriage, abortion and ectopic pregnancy, respectively.
Associations between adverse neonatal outcomes and
BMI and GWG
Table 3 presents associations between adverse neonatal
outcomes and BMI and GWG.
Preterm birth
The PTB rate among all women was 6.1%, ranging from
4.0% among women with no previous PTB or pregnancy
loss to 13.3% among women with a previous preterm birth.
Observed rates were highest among women who were
underweight or obese, women below or above their recom-
mended GWG and among women who smoked. However,
after adjusting for other maternal characteristics, only hav-
ing above recommended GWG was significantly associated
with preterm birth (overall and among primigravidas).
Small-for-gestational-age
The SGA birth rate was 8.1%, ranging from 6.7% among
women with no previous PTB or pregnancy loss to 10.5%
among primigravidas. Women who were underweight,were below their recommended GWG and smoked pre-
natally were significantly more likely to have an SGA baby.
Large-for-gestational-age
The LGA birth rate was 11.3%, ranging from 7.5% among
primigravidas to 14.9% among multigravid women with
no previous PTB or pregnancy loss. Women who were
overweight or obese and were above their recommended
GWG were significantly more likely to have an LGA baby.
Women whose GWG was below recommendations and
women who smoked prenatally were less likely to have an
LGA baby.
Generally, the direction of effects for PTB, SGA and
LGA remained the same across the four obstetric groups
though the magnitude of effects and statistical significance
of associations varied. BMI, GWG and smoking were
more commonly associated with infant weight (either
SGA or LGA) than with PTB. Of the three determinants,
only GWG was significantly associated with all outcomes.
The small number of women with a previous PTB limited
the statistical power to detect significant associations in
this group (Table 3).
PAFs for adverse neonatal outcomes
Table 4 presents positive and negative PAFs for adverse
neonatal outcomes. Negative PAFs reflect protective
ORs in Table 3. We focus on positive PAFs, which esti-
mate the independent contribution of each determinant
to PTB, SGA and LGA (i.e., after adjusting for the other
two determinants and other covariates).
Preterm birth
Among all women, above recommended GWG contrib-
uted to 18.2% of PTB, while low BMI, high BMI and
prenatal smoking each contributed to less than 5% of
PTB. The pattern among primigravidas and multigravi-
das with no previous PTB or pregnancy loss was similar
to that among all women. Above recommended GWG
contributed to over a third of PTB among primigravidas
and multigravidas with no previous PTB or pregnancy
loss (33.9% and 38.7% respectively). Among women who
had experienced a previous PTB, only the PAF of pre-
natal smoking was positive (5.4%).
Small-for-gestational-age
Among all women, below recommended GWG contrib-
uted more (9.2%) to SGA births than prenatal smoking
(8.7%) or underweight BMI (5.3%), although the odds of
having an SGA baby were higher among women who
smoked and were underweight (Table 3). Below recom-
mended GWG, prenatal smoking and underweight BMI
contributed to SGA births in all four obstetric groups.
The highest PAF due to below recommended weight
gain was among multigravidas with no previous PTB or









Previous early pregnancy lossa
(n = 21,300)
No previous early pregnancy
loss (n = 21,600)
Percent of sample 33.8 5.7 30.0 30.5
Determinants
Prepregnancy BMI
<18.5 6.0 7.1 6.2 5.3 5.4
18.5-24.9 59.7 63.3 51.3 58.1 58.4
25.0-29.9 20.9 17.6 22.9 23.1 22.3
≥30 13.5 12.0 19.6 13.5 13.9
Gestational weight gain
<recommended 18.6 16.6 18.0 19.4 20.2
=recommended 23.0 22.1 23.2 22.3 24.9
>recommended 59.4 61.3 58.7 58.3 54.9
Smoked 3rd trimester 10.4 7.7 17.2 13.7 10.0
Covariates
Maternal age
≤24 15.3 23.6 11.9 12.4 9.5
25-29 34.1 40.4 27.7 29.0 33.5
30-34 33.4 26.1 37.7 35.4 37.8
≥35 17.5 9.8 22.7 23.2 19.3
Maternal education
Less than high school 6.8 5.1 12.4 7.8 6.7
High school graduate 19.4 17.7 22.7 20.3 19.8
Post-secondary diploma 37.7 38.1 41.6 36.8 37.4
University graduate 36.1 39.2 23.3 35.2 36.1
Low-income-cut-off (LICO)
≤LICO 18.0 14.9 26.2 19.1 19.1
>LICO 74.0 75.3 69.1 74.1 74.0
Missing 8.0 9.8 4.7 6.9 6.9
Short stature 6.4 5.6 6.8 5.8 7.7
World region of birth
Canada 76.7 77.8 82.2 76.4 74.9
Europe/Western nations 6.0 5.8 4.4 6.4 5.9
Africa/Caribbean 2.3 2.2 3.4 2.6 1.9
Middle East/North Africa 2.6 2.6 2.3 1.9 3.3
Latin America 2.3 1.8 1.3 2.2 3.2
East Asia/South East Asia/Pacific Islands 5.7 5.4 3.0 6.4 5.7
South Asia 4.5 4.5 3.5 4.1 5.1
Medical conditions prior to pregnancy 15.2 14.3 20.5 16.6 13.8
Medical conditions during pregnancy 24.4 24.8 32.2 25.1 21.8
Depression prior to pregnancy 15.5 13.8 20.2 17.3 14.6
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Table 2 Percent of population with maternal characteristics* (Continued)
Perceived stress during pregnancy
Not stressful 43.1 46.4 34.2 41.6 42.6
Somewhat stressful 44.9 44.7 47.6 44.7 45.0
Very stressful 12.0 8.9 18.2 13.8 12.4
No support during pregnancy 12.8 10.0 16.8 14.7 13.3
*Subgroup sample sizes do not add up to the total due to rounding to the nearest 100, as explained in the methods. Abbreviations: PTB – preterm birth,
BMI – body mass index.
aEarly pregnancy loss - miscarriage, abortion and/or ectopic pregnancy.
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smoking was among multigravidas with no previous
PTB but with a previous pregnancy loss (13.0%); and the
highest PAF due to underweight BMI was among primi-
gravidas (7.5%).
Large-for-gestational-age
Overall, above recommended GWG contributed more
(15.9%) to LGA births than being overweight (6.5%) or
obese (8.9%). Larger PAFs due to excess GWG were ob-
served among primigravidas and multigravidas with no
previous PTB or pregnancy loss, than among multigravi-
das with a previous pregnancy loss but no previous PTB.
Similar to the results for PTB, above recommended
GWG contributed to over a third (37.9%) of LGA births
in primigravidas. It was not possible to estimate the
PAFs for multigravidas with a previous PTB due to the
small size of this group (Table 4).
Discussion
The results of this nationally representative study indicate
that low or high prepregnancy BMI and inadequate or ex-
cess GWG are important contributors to PTB, SGA and
LGA infants in Canada. Due to almost 60% of women
gaining above the recommended weight for their prepreg-
nancy BMI, excess GWG contributed more to adverse
outcomes than high BMI, to 18.2% of PTB and 15.9% of
LGA overall. Although the distribution of BMI and GWG
was similar across obstetric groups, their impact on stud-
ied outcomes was attenuated among women with a previ-
ous PTB or early pregnancy loss. The contribution of BMI
and GWG to PTB and SGA exceeded that of prenatal
smoking. This is the first study to report population-level
contributions of maternal weight to PTB, SGA and LGA
in Canada.
Our study adds to existing evidence on the association
between maternal weight and adverse neonatal out-
comes, by estimating the PAFs of PTB, SGA and LGA
that could potentially be prevented if all women began
their pregnancy with a normal BMI and had a GWG
that was within the recommended range. As the PAF is
a factor of both the risk associated with a characteristic
and the prevalence of that characteristic, we observedthe largest PAFs in subgroups where significant risk and
high prevalence converged. For example, the highest
odds of LGA (aOR: 2.01[1.12-3.61]) and PTB (aOR: 2.02
[1.13-3.63]) were observed among primigravidas with
above recommended GWG and primigravidas also had
the highest prevalence of above recommended GWG
(61.3%), leading to above recommended GWG contrib-
uting to a striking 38.9% of LGA and 33.9% of PTB in
these women. A similar pattern was observed among
multigravid women with no previous PTB or pregnancy
loss. However, the pattern varied among women with a
previous PTB or pregnancy loss. Among these women,
GWG did not contribute significantly to PTB or LGA al-
though the prevalence of excess GWG was similar to
that in other groups. This varied pattern is likely a re-
flection of differences in the distribution of risk factors
across groups. For example, the PTB rate in women with a
previous PTB was 13.2%, more than twice the population
norm (6.1%), suggesting risk factors for PTB not related to
maternal weight. The higher risks associated with excess
GWG among primigravidas compared to multigravidas, is
likely in part attributable to the fact that on average, prim-
iparous women gained more weight during their preg-
nancy compared to multiparous women.
The utility of the PAF for informing public health pre-
vention policy is illustrated further by the fact that among
all women, even though the risk of having an SGA infant
associated with underweight BMI was higher than that
associated with below recommended GWG (aOR: 2.04
[1.46-2.52] versus 1.56 [1.20-2.03]); the contribution of
underweight BMI to SGA was lower than that of below
recommended GWG (5.3% versus 9.2%) because fewer
women were underweight than below their recommended
GWG (6.0% versus 18.6%). Although PAFs are theoretical,
as they are based on a particular risk factor being com-
pletely eliminated, our results nevertheless illustrate that
maternal weight plays an important role in the incidence
of neonatal morbidity at the population level. Studying in-
dividual associations of risk alone cannot provide evidence
of population-level impacts.
Our findings are difficult to compare to those of other
studies due to differences in study methods and under-
lying characteristics of study populations. For example,
Table 3 Rate (%) and adjusted odds ratios (aORs) of adverse neonatal outcomes associated with BMI, GWG and
prenatal smoking*
PTB SGA LGA
% aOR (95% CI) % aOR (95% CI) % aOR (95% CI)
All women (n = 71,200) 6.1 8.1 11.3
Prepregnancy BMI
<18.5 8.4 1.55 [0.96 , 2.52] 20.5 2.04 [1.46, 2.84] 4.3 0.64 [0.33, 1.20]
18.5-24.9 5.6 Reference 10.0 Reference 7.5 Reference
25.0-29.9 6.1 0.98 [0.72, 1.33] 8.2 0.95 [0.74, 1.22] 11.4 1.38 [1.08, 1.75]
≥30 7.4 1.02 [0.73,1.42] 8.6 0.86 [0.63, 1.15] 14.1 1.89 [1.45, 2.47]
Gestational weight gain
< recommended 6.5 1.35 [0.92, 1.97] 16.1 1.56 [1.20, 2.03] 4.6 0.57 [0.39, 0.84]
= recommended 4.5 Reference 10.9 Reference 7.7 Reference
> recommended 6.7 1.45 [1.06, 1.98] 7.7 0.70 [0.56, 0.87] 11.0 1.34 [1.04, 1.72]
Smoked 3rd trimester
Yes 8.9 1.31 [0.92, 1.86] 18.4 2.06 [1.59, 2.67] 2.8 0.26 [0.16, 0.43]
No 5.8 Reference 9.1 Reference 9.7 Reference
Primigravidas (n = 24,000) 6.8 10.5 7.5
Prepregnancy BMI
<18.5 8.7 1.63 [0.77, 3.47] 28.3 2.47 [1.53, 3.99] 0.8 0.14 [0.005, 4.69]
81.5-24.9 6.1 Reference 12.2 Reference 6.1 Reference
25.0-29.9 8.6 1.30 [0.80, 2.12] 10.4 0.89 [0.59, 1.34] 7.5 1.12 [0.67, 1.87]
≥30 6.6 0.86 [0.45, 1.66] 12.1 0.97 [0.61, 1.57] 11.4 1.89 [1.11, 3.21]
Gestational weight gain
< recommended 6.6 1.60 [0.78, 3.29] 20.8 1.40 [0.92, 2.12] 2.1 0.49 [0.17, 1.41]
= recommended 3.9 Reference 15.9 Reference 4.1 Reference
> recommended 7.9 2.02 [1.13, 3.63] 9.9 0.61 [0.44, 0.86] 8.8 2.01 [1.12, 3.61]
Smoked 3rd trimester
Yes 8.2 1.04 [0.53, 2.04] 27.4 2.32 [1.49, 3.62] 2.1 0.29 [0.08, 1.13]
No 6.7 Reference 11.8 Reference 7.0 Reference
Multigravidas, previous PTB (n = 4,000) 13.3 7.4 10.9
Prepregnancy BMI
<18.5 8.6 0.70 [0.05, 9.26] 19.7 1.79 [0.20, 15.69] 0 –b
18.5-24.9 15.0 Reference 9.3 Reference 7.2 Reference
25.0-29.9 9.5 0.56 [0.19, 1.67] 6.8 1.14 [0.26, 4.92] 10.6 1.58 [0.33, 7.49]
≥30 14.9 0.89 [0.36, 2.22] 5.9 0.42 [0.08, 2.18] 3.8 0.55 [0.07, 4.34]
Gestational weight gain
< recommended 13.1 0.83 [0.22, 3.10] 17.1 1.40 [0.35, 5.58] 6.9 1.24 [0.08, 18.45]
= recommended 15.6 Reference 12.8 Reference 4.6 Reference
> recommended 12.5 0.93 [0.33, 2.59] 4.5 0.30 [0.08, 1.14] 7.7 1.01 [0.14, 7.45]
Smoked 3rd trimester
Yes 16.0 1.45 [0.46, 4.61] 12.8 1.77 [0.43, 7.24] 0 –b
No 12.8 Reference 7.8 Reference 8.3 Reference
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Table 3 Rate (%) and adjusted odds ratios (aORs) of adverse neonatal outcomes associated with BMI, GWG and
prenatal smoking* (Continued)




<18.5 10.3 1.90 [0.73, 4.93] 14.2 1.75 [0.84, 3.66] 6.7 1.04 [0.37, 2.90]
18.5-24.9 5.7 Reference 9.2 Reference 7.5 Reference
25.0-29.9 5.9 1.00 [0.57, 1.75] 6.4 0.72 [0.44, 1.19] 12.3 1.53 [1.00, 2.36]
≥30 7.2 0.92 [0.47, 1.80] 8.3 0.84 [0.46, 1.54] 16.9 2.61 [1.61, 4.23]
Gestational weight gain
< recommended 8.1 1.14 [0.59, 2.19] 14.2 1.65 [0.96, 2.83] 5.0 0.41 [0.20, 0.81]
= recommended 5.9 Reference 8.2 Reference 9.9 Reference
> recommended 5.7 0.93 [0.53, 1.62] 7.1 0.83 [0.50, 1.36] 11.4 1.02 [0.64, 1.63]
Smoked 3rd trimester
Yes 8.8 1.77 [0.97, 3.23] 16.3 2.26 [1.40, 3.64] 10.8 0.23 [0.10, 0.51]
No 5.8 Reference 7.5 Reference 3.6 Reference
Multigravidas, no previous PTB, no previous lossa (n = 21,600) 4.0 6.7 14.9
Prepregnancy BMI
<18.5 6.1 2.14 [0.56, 8.20] 15.3 1.81 [0.84, 3.88] 6.9 0.93 [0.31, 2.76]
18.5-24.9 3.5 Reference 8.1 Reference 9.3 Reference
25.0-29.9 3.3 0.75 [0.37, 1.51] 8.3 1.24 [0.76, 2.03] 14.2 1.46 [0.99, 2.14]
≥30 6.5 1.21 [0.59, 2.50] 6.2 0.78 [0.38, 1.61] 16.8 1.79 [1.14, 2.80]
Gestational weight gain
< recommended 3.8 1.98 [0.71, 5.51] 13.6 1.76 [1.03, 3.03] 6.2 0.66 [0.34, 1.26]
= recommended 2.1 Reference 8.2 Reference 9.9 Reference
> recommended 4.9 2.52 [0.99, 6.37] 6.4 0.80 [0.49, 1.30] 13.8 1.36 [0.88, 2.08]
Smoked 3rd trimester
Yes 7.0 1.13 [0.50, 2.59] 15.2 1.92 [1.10, 3.35] 3.3 0.29 [0.12, 0.71]
No 3.7 Reference 7.6 Reference 12.1 Reference
*Subgroup sample sizes do not add up to the total due to rounding to the nearest 100, as explained in the methods. Statistically significant aORs are bolded.
Abbreviations: PTB – preterm birth, SGA – small-for-gestational-age, LGA – large-for-gestational-age, BMI – body mass index.
aEarly pregnancy loss – miscarriage, abortion and/or ectopic pregnancy.
bNo cases of LGA in these subgroup.
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based study in the United Kingdom to obese BMI [23];
and Djelantik et al. attributed 6.6% of PTB in Amsterdam
to overweight or obese BMI [24]. However, neither of
these studies controlled for GWG. We found that after
adjusting for GWG, overweight or obese BMI did not con-
tribute significantly to PTB, whereas more than recom-
mended GWG contributed to almost one in five (18.2%)
preterm births. A South Carolina study which investigated
independent contributions of BMI and GWG found that
inadequate GWG contributed to 8.1% of very low birth-
weight (VLBW, 500-1,499 g) and underweight, overweight
and obese pregnancy BMI contributed to 8.3%, 3.5% and
7.0% of VLBW respectively [25]. But it is not possible to
compare our results, as they dichotomized GWG as less
than adequate and adequate (i.e., grouped women with
recommended GWG with women with excess GWG) andlooked at the impact on low birthweight (LBW) rather
than on the constituents of LBW: PTB and SGA, which
are known to have different etiologic determinants [6,26].
The importance of looking at PTB and SGA separately, as
well as GWG, is highlighted by our findings that excess
GWG contributed significantly to PTB but not SGA
infants, while underweight BMI and inadequate GWG
contributed to both PTB and SGA, but with a larger con-
tribution to SGA. Recognition of such differences facili-
tates the development of more appropriate preventive
interventions for PTB and SGA. Studies have consistently
found that obesity contributes significantly to the occur-
rence of LGA or macrosomia [23,24,27], with PAFs ran-
ging from 7.4% in a UK hospital population in 2004-2008
[23] to 25.7% in Alabama in 1995-1999 [27]. The PAFs of
LGA for overweight and obese BMI in our study fell
within this range, 6.5% and 8.9% respectively. The large
Table 4 Adjusted population attributable fractions (PAFs) of adverse neonatal outcomes due to BMI, GWG and
prenatal smoking*
PAF (%, 95 CI)
Characteristic Prevalence (%) of characteristic PTB SGA LGA
All women (n = 71,200)
Underweight 6.0 2.6 [2.5, 2.7] 5.3 [5.2, 5.4] −1.4 [-1.4, -1.3]
Overweight 20.9 −0.4 [-0.6, -0.2] −0.8 [-0.9, -0.7] 6.5 [6.3, 6.6]
Obese 13.5 0.3 [0.1, 0.4] −1.6 [-1.7, -1.5] 8.9 [8.8, 9.1]
< recommended GWG 18.6 4.7 [4.4, 5.0] 9.2 [9.0, 9.4] −6.3 [-6.4, -6.2]
> recommended GWG 59.4 18.2 [17.8, 18.7] −16.3 [-16.4, -16.1] 15.9 [15.4, 16.3]
Smoked 3rd trimester 10.4 3.2 [3.0, 3.3] 8.7 [8.6, 8.8] −7.1 [-7.2, -7.0]
Primigravidas (n = 24,000)
Underweight 7.1 3.3 [3.1, 3.5] 7.5 [7.4, 7.7] −4.6 [-4.7, -4.5]
Overweight 17.6 4.8 [4.5, 5.1] −1.4 [-1.6, -1.3] 2.0 [1.7, 2.2]
Obese 12.0 −1.7 [-2.0, -1.5] −0.1 [-0.2, 0.1] 8.9 [8.6, 9.1]
< recommended GWG 16.6 5.7 [5.5, 6.0] 6.1 [5.8, 6.5] −5.1 [-5.3, -4.9]
> recommended GWG 61.3 33.9 [33.1, 34.6] −22.8 [-23.4, -22.3] 37.9 [37.1, 38.6]
Smoked 3rd trimester 7.7 0.3 [0.1, 0.5] 7.5 [7.4, 7.6] −5.1 [-5.2, -5.0]
Multigravidas, previous PTB (n = 4,000)
Underweight 6.2 −1.4 [-1.6 ,-1.2] 4.6 [4.2, 5.1] –a
Overweight 22.9 −10.5 [-11.1, -9.9] 1.9 [1.3, 2.5] –a
Obese 19.6 −2.1 [-2.6, -1.7] −14.0 [-14.9,-13.2] –a
< recommended GWG 18.0 −3.0 [-3.6, -2.4] 8.0 [7.1, 8.9] –a
> recommended GWG 58.7 −3.6 [-5.1, -2.1] −54.8 [-57.1, -52.4] –a
Smoked in 3rd trimester 17.2 5.4 [4.9, 6.0] 9.7 [9.0, 10.4] –a
Multigravidas, no previous PTB, previous lossb
(n = 21,300)
Underweight 5.3 3.5 [3.3, 3.7] 3.2 [3.1, 3.4] 0.1 [0.0, 0.2]
Overweight 23.1 −0.05 [-0.4, 0.3] −5.6 [-5.9, -5.4] 8.9 [8.6, 9.2]
Obese 13.5 −1.2 [-1.4, -0.9] −2.2 [-2.4, -2.0] 13.0 [12.7, 13.2]
< recommended GWG 19.4 2.7 [2.3, 3.1] 11.0 [10.6, 11.4] −11.4 [-11.6, -11.1]
> recommended GWG 58.3 −3.7 [-4.5, -2.8] −8.6 [-9.3, -7.9] 1.1 [0.2, 1.9]
Smoked 3rd trimester 13.7 8.0 [7.7, 8.2] 13.0 [12.7, 13.2] −13.2 [-13.4,-13.0]
Multigravidas, no previous PTB, no previous lossb
(n = 21,600)
Underweight 5.4 4.2 [4.0, 4.5] 3.8 [3.7, 4.0] −0.2 [-0.3, -0.1]
Overweight 22.3 −5.9 [-6.4, -5.5] 3.9 [3.6, 4.2] 7.6 [7.4, 7.8]
Obese 13.9 3.4 [3.0, 3.8] −2.5 [-2.7, -2.3] 7.9 [7.7, 8.1]
< recommended GWG 20.2 9.5 [9.1, 9.9] 12.3 [11.6, 13.1] −5.0 [-5.2, -4.8]
> recommended GWG 54.9 38.7 [37.8, 39.5] −9.3 [-10.0, -8.6] 15.2 [14.6, 15.8]
Smoked 3rd trimester 9.0 1.6 [1.2, 1.9] 7.0 [6.8, 7.2] −5.4 [-5.4, -5.3]
*Subgroup sample sizes do not add up to the total due to rounding to the nearest 100, as explained in the methods.
Abbreviations: PAF – population attributable fraction, PTB – preterm birth, SGA – small-for-gestational-age, LGA- large-for-gestational-age, BMI – body mass index,
GWG – gestational weight gain.
aPAFs cannot be estimated due to the small sample size / small number of LGA babies in this group.
bEarly pregnancy loss – miscarriage, abortion and/or ectopic pregnancy.
Dzakpasu et al. BMC Pregnancy and Childbirth  (2015) 15:21 Page 9 of 12PAF reported in the Alabama study reflects the high
prevalence of obesity (≥200 lbs) in this population (21.2%
versus 13.5% in our study).The objective of this study was not only to estimate
the contribution of BMI and GWG to adverse neonatal
outcomes, but to also compare this contribution to that
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found that overall below recommended and above rec-
ommended GWG contributed more to PTB than pre-
natal smoking (4.7%, 18.2% versus 3.2% respectively),
while underweight BMI contributed less (2.6%). Simi-
larly, below recommended GWG contributed more to
SGA than prenatal smoking (9.2% versus 8.7%), while
underweight BMI contributed less (5.3%). This pattern
varied across obstetric groups, with prenatal smoking
contributing to a higher proportion of PTB and SGA
than BMI or GWG, among women with a previous PTB
or pregnancy loss. As stated earlier, this variation in pat-
tern likely reflects differences in the distribution of
underlying risk factors for PTB and SGA across groups.
Our results are similar to that of a 2003-2004 study in
Amsterdam which found that the contribution of pre-
pregnancy overweight and obesity (BMI ≥ 25) to PTB
exceeded that of prenatal smoking (6.6% versus 5.5%) [24].
This study did not investigate contributions of GWG or
underweight BMI.
Recognition of the contribution prenatal smoking makes
to adverse pregnancy outcomes has led to considerable ef-
forts to develop smoking cessation interventions during
pregnancy [28]. However, the contribution of maternal
weight to adverse pregnancy outcomes has not been simi-
larly quantified and less attention has been paid to devel-
oping interventions aimed at healthy maternal weight
during pregnancy. Our results suggest that due to the
much higher prevalence of inadequate GWG (18.6%) and
excess GWG (59.4%) compared with prenatal smoking
(10.4%), maternal weight in general and GWG in particu-
lar contributed significantly more to PTB and SGA than
prenatal smoking. Thus, from a public health perspective,
the importance of healthy maternal weight for the studied
outcomes exceeds that of prenatal smoking. Unfortu-
nately, although there is evidence that counselling from a
health care provider regarding GWG is effective in helping
women plan to gain the recommended amount of weight
[29,30], there is also evidence suggesting that few women
receive such counselling [31]. In Canada, as in many other
high-income countries, prenatal smoking is decreasing
[32], while overweight and obesity are increasing [7]. As
this trend continues, the already large PAFs for BMI and
GWG are likely to increase while PAFs for prenatal smok-
ing decrease. This was observed by Lu et al. in Alabama
between 1980-84 and 1995-99. Although there was no sig-
nificant change in the risk of LGA associated with obesity
(≥200 lbs), the PAF of LGA attributed to obesity increased
from 6.5% to 19.1%, as the prevalence of obesity increased
from 7.7% to 21.2% [27]. Cnattingius et al. asserted in
2002 that from a public health perspective, maternal over-
weight and obese BMI was one of the most important
modifiable risk factors for pregnancy complications and
adverse pregnancy outcomes [9]. Our findings supportand go beyond this assertion to also highlight the import-
ance of underweight BMI and inadequate and excess
GWG.
Our study has several limitations. Self-reported data
on BMI and GWG are highly correlated with measured
values, but they tend to underestimate these measures
[33,34]. This could have led to an overestimation of the
risk associated with overweight or obese BMI and excess
GWG, as women reporting these characteristics are
more likely to be at the higher end of the BMI and
GWG spectrum and therefore at increased risk of ad-
verse outcomes [33]. Underestimation of these measures
could, however, also have led to more conservative PAFs,
as PAFs take into consideration the prevalence of the
characteristic. Due to a lack of data on per trimester
weight gain, as per IOM guidelines, we assumed a 2 kg
weight gain in the first trimester and linear weight gain
in the remainder of the pregnancy, although some stud-
ies suggest alternate patterns [35]. It is possible that if
there was excess gain above 2 kg in the first trimester,
that could be contributing to adverse outcomes, rather
than second or third trimester excess weight gain. There
is a need for more research on timing of GWG and neo-
natal outcomes. Data did not include a breakdown of
PTB by aetiology, so we were unable to assess whether
the contribution of maternal weight varied by PTB sub-
types [36]. The importance of a previous PTB as a risk
factor for adverse outcomes in a subsequent pregnancy
may vary with the degree of PTB (e.g. at 31 weeks vs at
36 weeks); however we were not able to assess this as
data did not include the gestational age of previous
PTBs. Data also only included smoking status in the
third trimester. Additionally, studying outcomes overall
and across four obstetric groups required us to make
multiple comparisons which is known to increase the
chance of significant findings [37]. However, the associa-
tions we noted are plausible and we reported precise
confidence intervals to support interpretation. Finally,
our data excluded multiple births and infant deaths,
making our population healthier than the general popu-
lation; and some residual confounding may remain due
to unmeasured factors. For example, we did not have in-
formation on gestational diabetes which is a risk factor
for LGA. However, we note that other data found gesta-
tional diabetes contributed far less to LGA (2-8%) com-
pared to excess GWG (33.3-37.7%) [38].
Conclusions
Our study provides evidence that maternal weight in
general, and GWG in particular, contributes significantly
to the occurrence of PTB, SGA and LGA in Canada.
The contribution of these modifiable risk factors rivals
that of prenatal smoking, and the contributions of high
BMI and excess GWG in particular are likely to increase
Dzakpasu et al. BMC Pregnancy and Childbirth  (2015) 15:21 Page 11 of 12as population rates of overweight and obesity rise. These
findings highlight the public health importance of pro-
moting a healthy prepregnancy BMI and appropriate
GWG.
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